Saba Capital Management L.P. Sells 32,108 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Saba Capital Management L.P. lessened its position in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 17.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 147,590 shares of the company's stock after selling 32,108 shares during the period. Saba Capital Management L.P. owned about 0.17% of Pediatrix Medical Group worth $1,936,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Parkside Financial Bank & Trust increased its holdings in Pediatrix Medical Group by 36.1% in the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after buying an additional 1,040 shares in the last quarter. Nomura Asset Management Co. Ltd. grew its stake in shares of Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after acquiring an additional 1,220 shares during the period. AlphaQuest LLC grew its stake in shares of Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after acquiring an additional 2,012 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Pediatrix Medical Group by 6.1% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 49,002 shares of the company's stock valued at $643,000 after purchasing an additional 2,801 shares during the last quarter. Finally, Illinois Municipal Retirement Fund lifted its position in Pediatrix Medical Group by 7.8% during the fourth quarter. Illinois Municipal Retirement Fund now owns 47,409 shares of the company's stock valued at $622,000 after purchasing an additional 3,411 shares during the period. Hedge funds and other institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Price Performance

Shares of MD traded down $0.86 during trading hours on Thursday, reaching $14.32. 615,946 shares of the stock traded hands, compared to its average volume of 852,343. The company has a market cap of $1.23 billion, a P/E ratio of -11.93, a price-to-earnings-growth ratio of 1.74 and a beta of 1.26. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The company's 50-day moving average price is $13.78 and its two-hundred day moving average price is $14.13. Pediatrix Medical Group, Inc. has a 52-week low of $6.62 and a 52-week high of $17.67.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, beating the consensus estimate of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $458.36 million for the quarter, compared to the consensus estimate of $451.44 million. During the same period in the previous year, the business earned $0.20 earnings per share. The business's revenue was down 7.4% on a year-over-year basis. On average, analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on MD shares. UBS Group decreased their target price on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a research note on Monday, May 12th. Truist Financial reduced their target price on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a report on Friday, April 11th. Wall Street Zen upgraded shares of Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research note on Wednesday, January 22nd. Finally, Macquarie lifted their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, Pediatrix Medical Group presently has an average rating of "Hold" and an average target price of $16.67.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.